Pfizer

24 Archived Projects

Title Investigator Start
End
HIV Clinical Scholars Fellowship Lin
A Randomized, Double Blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy &Safety of Atorvastatin in Patients w/ Clinically Isolated Syndrome & High Risk for Conversion to M.S. Bluestone
Twelve-Week Study Evaluating the Safety and Efficacy of Varenicline Tartrate ( CP-526,555) in Comparison to Zyban for Smoking Cessation Reus
International Fellowship Program in Drug Development Giacomini
A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial of a Novel CCR5 Antagonist, UK427,857, for the Treatment of Antiretroviral-Experienced HIV-1-Infected Subjects Luetkemeyer
The Use of Nelfinavir During Acute or Early HIV Infection - Safety, Tolerability, Durablilty and Resistance Hare
A Prophylactic Strategy Using Voriconazole vs. Inhaled Amphotericin to Prevent Invasive Aspergillosis in Lung Transplant Recipients Chin-Hong
Phase IV Open-Label, Non-comparative Trial of IV Anidulafungin followed by Oral Azole Therapy for the Treatment of Candidemia and Invasive Candidiasis Chin-Hong
Pfizer A4001027: Observational Phase Extension Luetkemeyer
QB3-UCSF Pfizer Collaboration Kelly
A8851009: A Prospective, Randomized Trial Comparing the Efficacy of Anidulafungin and Voriconazole in Combination to that of Voriconazole Alone When Used For Primary Therapy of Proven or Probable Invasive Aspergillosis Chin-Hong
Pfizer International Growth Study (KIGS) - Protocol TRN 87-052-45 (CCID A6281276) Rosenthal
Rifabutin Based Therapy for Eradication of Staph Carriage in HIV-Infected Individuals with Prior Skin Structure Infections Chambers
Mycotic Ulcer Treatment Trial (MUTT) Acharya
Efficacy and Safety of Eraxis/Ecalta (Anidulafungin) Compared to Cancidas (Caspofungin) in Patients with Candida Deep Tissue Infection: A Phase 4 Study Chin-Hong
ViiV Healthcare A4001098 Luetkemeyer
Effects of Maraviroc on HIV-related Kaposi Sarcoma Maurer
Accelerating and Intensifying Tuberculosis Case Finding in Uganda Davis
Study to Evaluate the Efficacy, Safety and Tolerability of Desvenlafaxine Succinate Sustained-Release (DVS SR) in the Treatment of Children and Adolescent Outpatients with Major Depressive Disorder Hendren
A 6-Month Extension Study to B2061032 to Evaluate Desvenlafaxine Succinate Sustained-Release (DVS SR) Tablets in the Treatment of Children and Adolescent Outpatients with MDD Hendren
Description of Infant Microbiota Evolution Study (DIMES) Cabana
UCSF Cutaneous Immunology Core: OSM Project Rosenblum
Phase 3 study of PD-0332991 (Oral CDK4/6 inhibitor) plus Letrozole versus placebo plus Letrozole for postmenopausal women with ER (+), HER2 (-) breast cancer who have not received prior systemic anti cancer therapies
Exploring the Role of CDK4 and CDK6 in Melanoma Maintenance McMahon